KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,821,000 | +104.8% | 21,252 | +18.3% | 0.00% | +50.0% |
| Q2 2017 | $1,866,000 | +63.0% | 17,964 | +23.2% | 0.00% | +100.0% |
| Q1 2017 | $1,145,000 | +88.6% | 14,578 | +8.0% | 0.00% | 0.0% |
| Q4 2016 | $607,000 | +18.8% | 13,498 | +47.2% | 0.00% | 0.0% |
| Q3 2016 | $511,000 | +13.6% | 9,172 | +1.7% | 0.00% | – |
| Q2 2016 | $450,000 | +26.8% | 9,023 | +16.2% | 0.00% | – |
| Q1 2016 | $355,000 | -14.3% | 7,762 | +17.1% | 0.00% | – |
| Q4 2015 | $414,000 | +17.3% | 6,628 | +5.0% | 0.00% | – |
| Q3 2015 | $353,000 | +24.3% | 6,315 | +40.2% | 0.00% | – |
| Q2 2015 | $284,000 | +238.1% | 4,503 | +219.6% | 0.00% | – |
| Q1 2015 | $84,000 | +6.3% | 1,409 | 0.0% | 0.00% | – |
| Q4 2014 | $79,000 | – | 1,409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |